サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1628896

皮膚がん診断の世界市場：検査の種類別・がんの種類別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2024年～2032年)

Skin Cancer Diagnostics Market, By Test Type, By Cancer Type, By End-user, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 269 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
皮膚がん診断の世界市場：検査の種類別・がんの種類別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2024年～2032年)
出版日: 2024年12月04日
発行: AnalystView Market Insights
ページ情報: 英文 269 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

皮膚がん診断市場規模は2023年に91億1,450万米ドルとなり、2024年から2032年にかけてCAGR 5.90%で拡大

皮膚がん診断の市場力学

皮膚がん罹患率の上昇

皮膚がんは、ここ数十年で最も一般的ながんの1つであり、メラノーマと非メラノーマの両方の皮膚がんがより一般的になっています。世界保健機関 (WHO) によると、2020年には新たに150万人以上の皮膚がん患者が報告されると予測されています。また、欧州委員会の報告によると、2020年には、EU-27における新たながん診断のうち、皮膚黒色腫が占める割合は4%でした。また、がんによる全死亡者の1.3%を占めています。皮膚がんは、欧州で6番目に多く診断される悪性腫瘍です。皮膚がん診断の世界市場は、皮膚がんを含む他のがんの有病率が世界的に上昇していることから、予測期間を通じて拡大が見込まれています。

皮膚がん診断市場：主な考察

当社のリサーチアナリストが共有した分析によると、皮膚がん診断の世界市場は予測期間 (2024-2032年) に約5.90%のCAGRで毎年成長すると推定されます。

検査の種類別では、皮膚生検カテゴリーが2023年に最大の市場シェアを示すと予測されました。

がんの種類別では、2023年に非黒色腫が主要セグメントとなりました。

地域別では、北米が2023年の売上高でトップとなりました。p>

皮膚がん診断市場：セグメンテーション分析

皮膚がん診断の世界市場は、検査の種類、がんの種類、エンドユーザー、地域によって区分されます。

検査の種類別では、リンパ節生検、皮膚鏡検査、画像検査、皮膚生検、その他に区分されます。皮膚生検セグメントが2023年の市場シェアの大半を占めています。スクリーニングのための最もポピュラーな材料は皮膚生検であり、身体から少量の皮膚組織を採取する医療技術です。皮膚生検は、その精度、信頼性、適応性から皮膚がん診断のゴールドスタンダードです。また、効率的な皮膚がん検診と治療に不可欠です。皮膚生検の必要性は著しく増加しており、今後数年間は増加し続けると予想されます。心配な皮膚病変を顕微鏡で調べることができるため、このプロセスによって決定的な診断も得られます。さらに、皮膚がんの種類、病期や重症度などの属性、病変が悪性かどうかの判断にも役立ちます。

エンドユーザー別では、市場は病院・診療所、研究所、その他に区分されます。2023年の市場シェアでは、病院・診療所が皮膚がん診断業界を支配しています。予測期間を通じて、この分野も最も速い速度で増加すると予測されています。皮膚がんの有病率の上昇、診断ツールの改良、早期診断に対する意識の高まりなどが、皮膚がん診断市場の成長に寄与しています。病院ベースの皮膚がん診断サービスのニーズは、AIと遠隔皮膚治療 (teledermatology) を病院に統合することで増加し、診断のアクセシビリティと精度をさらに向上させることができます。

皮膚がん診断市場：地域別分析

地域的には、皮膚がん診断市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東アフリカの地域に広がっています。これらの地域は、ビジネスをもたらす国によってさらに分けられます。

2023年、北米の皮膚がん診断市場におけるシェアは最大でした。この地域で事業を展開する主要企業 (Dermlite LLC、Castle Biosciences Inc.、Dermtech Inc.など) が皮膚がん診断製品の研究開発に多額の支出を行っているため、北米の皮膚がん診断市場は大きく拡大しています。さらに、メラノーマ罹患率の急激な上昇により市場が拡大しています。さらに、北米は皮膚がん診断の開発をリードしており、同地域の産業に大きな潜在的可能性をもたらしています。

皮膚がん診断の市場は、紫外線暴露のような環境変数の増加、皮膚がんに対する意識の高まり、診断技術の向上により、アジア太平洋地域で最も速い速度で発展すると予想されます。皮膚がんの早期発見と治療を奨励する政府プログラムとともに、医療費の上昇と医療施設へのアクセスの容易さが市場拡大をさらに後押ししています。さらに、アジア太平洋地域では、これらの皮膚がん治療薬に対する規制当局の承認と、同地域の新興国市場における大規模かつ未発達な市場の存在が、アジア太平洋地域における皮膚がん診断市場の拡大を後押しすると予測されています。

皮膚がん診断市場：競合情勢

皮膚がん診断市場の上位企業としては、FOUNDATION MEDICINE, INC.、Castle Bioscience、DermTech、bioMerieux Inc.、DermaSensor, Inc.などが挙げられます。重要な企業は、高い品質基準を維持することを優先し、この地域の現在の消費者基盤を利用することで、大きな市場へのアクセスを獲得しています。マーケットプレースで信頼性を確立しているブランドは、この戦術から利益を得ることができます。このような企業は、最先端のインフラや技術に多大な投資を行っており、大量のサンプルを効率的に処理・分析することを可能にしています。市場での存在感を高めるため、企業は流通業者やその他の企業との戦略的活動も数多く行っています。例えば、診断技術開発企業のSkylineDx社は、2024年1月に欧州特許第3827101号を取得し、がん診断と個別化治療における画期的な進歩を遂げました。この特許は、遺伝子発現シグネチャーのレベルを用いて、原発性皮膚黒色腫の患者を分類し治療するための新しい技術を説明するものです。

目次

第1章 皮膚がん診断市場の概要

  • 調査範囲
  • 市場推定期間

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 皮膚がん診断の主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 皮膚がん診断市場：産業分析

  • PEST分析
  • ポーターのファイブフォース分析
  • 市場成長の見通し：マッピング
  • 規制体制の分析

第5章 皮膚がん診断市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19以後の影響分析

第6章 皮膚がん診断の市場情勢

  • 皮膚がん診断の市場シェア分析 (2023年)
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 皮膚がん診断市場：検査の種類別

  • 概要
    • セグメント別シェア分析：検査の種類別
    • リンパ節生検
    • 皮膚鏡検査
    • 画像検査
    • 皮膚生検
    • その他

第8章 皮膚がん診断市場：がんの種類別

  • 概要
    • セグメント別シェア分析：がんの種類別
    • 悪性黒色腫
    • 非黒色腫

第9章 皮膚がん診断市場：エンドユーザー別

  • 概要
    • セグメント別シェア分析：エンドユーザー別
    • 病院・診療所
    • 研究所
    • その他

第10章 皮膚がん診断市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • 英国
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋 (APAC)
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 韓国
    • 日本
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析：皮膚がん診断業界

  • 競合ダッシュボード
  • 企業プロファイル
    • FOUNDATION MEDICINE, INC.
    • Castle Bioscience
    • DermTech
    • bioMerieux Inc.
    • DermaSensor, Inc.
    • Quest Diagnostics Incorporated.
    • NeoGenomics Laboratories
    • SkylineDx
    • Abbott
    • F Hoffmann-La Roche Ltd
    • Others

第12章 AnalystViewの全方位的分析

目次
Product Code: ANV4429

REPORT HIGHLIGHT

Skin Cancer Diagnostics Market size was valued at USD 9,114.5 Million in 2023, expanding at a CAGR of 5.90% from 2024 to 2032.

The procedure for identifying and diagnosing skin cancer is called skin cancer diagnostics. This encompasses a number of methods, including molecular pathology, histology, immunohistochemistry, electron microscopy, physical examination, and biopsy. Among the cancers that impact the skin is skin cancer. Skin cancer comes in three primary forms: squamous cell carcinoma, malignant melanoma, and basal cell carcinoma. Globally, the incidence of skin cancer is rising due to factors including ageing populations and prolonged UV exposure, which is driving the market for skin cancer diagnostics. This is driving the need for efficient diagnostic tools. Furthermore, more people are being encouraged to have regular tests for skin cancer due to rising public awareness and educational initiatives regarding the significance of early diagnosis.

Skin Cancer Diagnostics Market- Market Dynamics

Rising Incidence of Skin Cancer

Skin cancer has been one of the most common types of cancer in recent decades, with both melanoma and non-melanoma skin cancers becoming more common. Over 1.5 million new instances of skin cancer were anticipated to be reported in 2020, according to the World Health Organization (WHO). In addition, the European Commission reports that in 2020, cutaneous melanoma accounted for 4% of all new cancer diagnoses in the EU-27. It was also responsible for 1.3% of all deaths from cancer. Skin cancer is the sixth most often diagnosed malignancy in Europe. The global market for skin cancer diagnostics is expected to expand throughout the forecast period as the prevalence of other cancers, including skin cancer, rises worldwide.

Skin Cancer Diagnostics Market- Key Insights

As per the analysis shared by our research analyst, the global Skin Cancer Diagnostics Market is estimated to grow annually at a CAGR of around 5.90% over the forecast period (2024-2032)

Based on test type segmentation, the skin biopsy category was predicted to show maximum market share in the year 2023

Based on cancer type segmentation, the non-melanoma was the leading segment in 2023

On the basis of region, North America was the leading revenue generator in 2023

Skin Cancer Diagnostics Market- Segmentation Analysis:

The Global Skin Cancer Diagnostics Market is segmented on the basis of Test Type, Cancer Type, End-user, and Region.

Based on test type, the market is segmented into Lymph Node Biopsy, Dermatoscopy, Imaging Tests, Skin Biopsy, and Others. The skin biopsy segment accounted for the majority of the market share in 2023. The most popular material for screening is skin biopsy, a medical technique in which a small sample of skin tissue is taken from the body. Skin biopsy is the gold standard for skin cancer diagnosis because of its precision, dependability, and adaptability. It is also essential for efficient skin cancer screening and treatment. The need for skin biopsies has increased significantly and is anticipated to continue to rise over the next several years. Because the worrisome skin lesion can be examined under a microscope, the process also yields a conclusive diagnosis. In addition, it assists in determining the type of skin cancer and its attributes, including stage and severity, as well as whether the lesion is malignant.

By end-user, the market is segmented into hospitals and clinics, laboratories, and others. With a significant market share in 2023, hospitals and clinics dominated the skin cancer diagnostics industry. Throughout the forecast period, this segment is also anticipated to increase at the fastest rate. The rising prevalence of skin cancer, improvements in diagnostic tools, and growing awareness of early diagnosis are all factors contributing to the skin cancer diagnostics market growth. The need for hospital-based skin cancer diagnostic services can be increased by integrating AI and teledermatology in hospitals, which can further improve diagnostic accessibility and accuracy.

Skin Cancer Diagnostics Market- Geographical Insights

Geographically, the Skin Cancer Diagnostics Market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

In 2023, North America's share in the regional skin cancer diagnostics market was the greatest. Due to significant expenditures made in the research and development of skin cancer diagnostics products by leading companies operating in the region, including Dermlite LLC, Castle Biosciences Inc., and Dermtech Inc., the North American skin cancer diagnostics market has experienced significant expansion. Additionally, the market is growing due to the sharp rise in melanoma incidence. Furthermore, North America is leading the way in the development of skin cancer diagnostics, which offers significant potential prospects for the region's industry.

The market for skin cancer diagnostics is expected to develop at the quickest rate in the Asia Pacific due to rising environmental variables like UV exposure, growing awareness of skin cancer, and improvements in diagnostic technology. Along with government programs encouraging early identification and treatment of skin cancer, rising healthcare costs and easier access to medical facilities further fuel market expansion. Additionally, it is projected that the regulatory approvals for these skin cancer medications in the Asia Pacific, together with the existence of a sizable and underdeveloped market in the region's developing nations, will support the expansion of the skin cancer diagnostics market in Asia Pacific.

Skin Cancer Diagnostics Market- Competitive Landscape:

Among the top companies in the skin cancer diagnostics market are FOUNDATION MEDICINE, INC., Castle Bioscience, DermTech, bioMerieux Inc., DermaSensor, Inc., and others. Important firms are prioritizing upholding high standards of quality and gaining access to a sizable market by using the region's current consumer bases. Brands that have established credibility in the marketplace can benefit from this tactic. These companies are making significant investments in cutting-edge infrastructure and technology, which enables them to process and analyze a high volume of samples efficiently. In order to increase their market presence, businesses also engage in a number of strategic activities with distributors and other businesses. For instance, the diagnostics technology developer SkylineDx was granted European Patent No. 3827101 in January 2024, marking a breakthrough in cancer diagnosis and tailored therapy. Using gene expression signature levels, the patent describes new techniques for classifying and treating individuals with primary cutaneous melanoma.

Recent Developments:

February 2024: MelaNodal Predict, a very sophisticated predictive gene expression test, was introduced by Quest Diagnostics to assist in customizing treatment choices for patients with melanoma, a type of skin cancer and one of the most prevalent diseases in the United States.

January 2024: DermaSensor Inc. was granted FDA approval for its noninvasive skin cancer assessment system, which employs artificial intelligence to identify common skin malignancies like SCC, basal cell carcinoma, and melanoma. Using an FDA-approved algorithm, the wireless, handheld gadget gives quick, objective data, enabling doctors to assess suspected lesions without the need for intrusive treatments.

April 2023: SkylineDx and NeraCare GmbH announced that they will work together to create a test that would allow life science businesses to launch critical melanoma treatments more quickly.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SKIN CANCER DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • FOUNDATION MEDICINE, INC.
  • Castle Bioscience
  • DermTech
  • bioMerieux Inc.
  • DermaSensor, Inc.
  • Quest Diagnostics Incorporated.
  • NeoGenomics Laboratories
  • SkylineDx
  • Abbott
  • F Hoffmann-La Roche Ltd
  • Others

GLOBAL SKIN CANCER DIAGNOSTICS MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Lymph Node Biopsy
  • Dermatoscopy
  • Imaging Tests
  • Skin Biopsy
  • Others

GLOBAL SKIN CANCER DIAGNOSTICS MARKET, BY CANCER TYPE- MARKET ANALYSIS, 2019 - 2032

  • Melanoma
  • Non-Melanoma

GLOBAL SKIN CANCER DIAGNOSTICS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals and Clinics
  • Laboratories
  • Others

GLOBAL SKIN CANCER DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Skin Cancer Diagnostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Skin Cancer Diagnostics Market Snippet by Test Type
    • 2.1.2. Skin Cancer Diagnostics Market Snippet by Cancer Type
    • 2.1.3. Skin Cancer Diagnostics Market Snippet by End-user
    • 2.1.4. Skin Cancer Diagnostics Market Snippet by Country
    • 2.1.5. Skin Cancer Diagnostics Market Snippet by Region
  • 2.2. Competitive Insights

3. Skin Cancer Diagnostics Key Market Trends

  • 3.1. Skin Cancer Diagnostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Skin Cancer Diagnostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Skin Cancer Diagnostics Market Opportunities
  • 3.4. Skin Cancer Diagnostics Market Future Trends

4. Skin Cancer Diagnostics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Skin Cancer Diagnostics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Skin Cancer Diagnostics Market Landscape

  • 6.1. Skin Cancer Diagnostics Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Skin Cancer Diagnostics Market - By Test Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Test Type, 2023 & 2032 (%)
    • 7.1.2. Lymph Node Biopsy
    • 7.1.3. Dermatoscopy
    • 7.1.4. Imaging Tests
    • 7.1.5. Skin Biopsy
    • 7.1.6. Others

8. Skin Cancer Diagnostics Market - By Cancer Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Cancer Type, 2023 & 2032 (%)
    • 8.1.2. Melanoma
    • 8.1.3. Non-Melanoma

9. Skin Cancer Diagnostics Market - By End-user

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-user, 2023 & 2032 (%)
    • 9.1.2. Hospitals and Clinics
    • 9.1.3. Laboratories
    • 9.1.4. Others

10. Skin Cancer Diagnostics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Skin Cancer Diagnostics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Skin Cancer Diagnostics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.8. France
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. France Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.9. Italy
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. Italy Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.10. Spain
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. United Kingdom Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. United Kingdom Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. United Kingdom Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.11. United Kingdom
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. United Kingdom Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. United Kingdom Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.3.11.5. United Kingdom Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.12. Russia
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Russia Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.13. Netherlands
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Netherlands Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.14. Sweden
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Sweden Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.2. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Skin Cancer Diagnostics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.9. South Korea
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. South Korea Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.10. Japan
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. Japan Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Skin Cancer Diagnostics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Skin Cancer Diagnostics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Skin Cancer Diagnostics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. FOUNDATION MEDICINE, INC.
    • 11.2.2. Castle Bioscience
    • 11.2.3. DermTech
    • 11.2.4. bioMerieux Inc.
    • 11.2.5. DermaSensor, Inc.
    • 11.2.6. Quest Diagnostics Incorporated.
    • 11.2.7. NeoGenomics Laboratories
    • 11.2.8. SkylineDx
    • 11.2.9. Abbott
    • 11.2.10. F Hoffmann-La Roche Ltd
    • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us